We are live on
!
Find out more
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
501
Destiny Tech100
DXYZ
$884M
| $786K | 0.01% |
+29,361
| New | +$847K |
2026 Q1
0 quarters
|
|
502
Affirm
AFRM
$25.6B
| $781K | ﹤0.01% |
+17,050
| New | +$985K |
2026 Q1
0 quarters
|
|
503
Archer Daniels Midland
ADM
$40B
| $780K | ﹤0.01% |
+10,732
| New | +$725K |
2026 Q1
0 quarters
|
|
504
Everpure Inc
P
$44.5B
| $777K | ﹤0.01% |
13,166
+7,682
| +140% | +$520K |
2025 Q4
1 quarter
|
|
505
Alpha Metallurgical Resources
AMR
$2.15B
| $776K | ﹤0.01% |
+3,782
| New | +$766K |
2026 Q1
0 quarters
|
|
506
Standard Lithium
SLI
$343M
| $768K | ﹤0.01% |
225,253
+82
| +0% | +$367 |
2025 Q4
1 quarter
|
|
507
Amphenol
APH
$201B
| $764K | ﹤0.01% |
12,094
-3,116
| -20% | -$219K |
2025 Q4
1 quarter
|
|
508
10x Genomics
TXG
$9.43B
| $758K | ﹤0.01% |
35,711
+6,310
| +21% | +$126K |
2025 Q4
1 quarter
|
|
509
Monolithic Power Systems
MPWR
$61.4B
| $757K | ﹤0.01% |
692
+260
| +60% | +$284K |
2025 Q2
3 quarters
|
|
510
Verizon
VZ
$184B
| $752K | ﹤0.01% |
14,978
-13,133
| -47% | -$609K |
2025 Q1
4 quarters
|
|
511
State Street SPDR S&P Metals & Mining ETF
XME
$4.02B
| $751K | ﹤0.01% |
6,955
-2,633
| -27% | -$308K |
2025 Q3
2 quarters
|
|
512
Intuitive Surgical
ISRG
$151B
| $750K | ﹤0.01% |
1,626
-18,491
| -92% | -$9.35M |
2025 Q2
3 quarters
|
|
513
Autolus Therapeutics
AUTL
$458M
| $749K | ﹤0.01% |
+542,857
| New | +$825K |
2026 Q1
0 quarters
|
|
514
iShares Semiconductor ETF
SOXX
$42.6B
| $747K | ﹤0.01% |
2,272
+92
| +4% | +$31.4K |
2025 Q3
2 quarters
|
|
515
Cytokinetics
CYTK
$8.89B
| $745K | ﹤0.01% |
11,301
+3,299
| +41% | +$210K |
2025 Q4
1 quarter
|
|
516
Freightos
CRGO
$40.7M
| $744K | ﹤0.01% |
+453,750
| New | +$860K |
2026 Q1
0 quarters
|
|
517
Aurinia Pharmaceuticals
AUPH
$2.23B
| $741K | ﹤0.01% |
50,000
+25,200
| +102% | +$368K |
2023 Q4
9 quarters
|
|
518
Sypris Solutions
SYPR
$41.2M
| $740K | ﹤0.01% |
+259,789
| New | +$826K |
2026 Q1
0 quarters
|
|
519
XPeng
XPEV
$9.23B
| $735K | ﹤0.01% |
42,947
+24,730
| +136% | +$459K |
2025 Q4
1 quarter
|
|
520
AT&T
T
$161B
| $734K | ﹤0.01% |
25,324
-43,218
| -63% | -$1.15M |
2022 Q4
13 quarters
|
|
521
Target
TGT
$71.2B
| $732K | ﹤0.01% |
6,042
-29,183
| -83% | -$3.29M |
2024 Q2
7 quarters
|
|
522
Blackstone Secured Lending
BXSL
$5.64B
| $729K | ﹤0.01% |
30,785
-67,664
| -69% | -$1.69M |
2025 Q3
2 quarters
|
|
523
EyePoint Inc
EYPT
$271M
| $726K | ﹤0.01% |
56,313
+8,536
| +18% | +$128K |
2025 Q4
1 quarter
|
|
524
Domino's
DPZ
$9.97B
| $724K | ﹤0.01% |
2,019
+1,278
| +172% | +$505K |
2025 Q3
2 quarters
|
|
525
Goodyear
GT
$1.27B
| $721K | ﹤0.01% |
108,744
+66,484
| +157% | +$560K |
2024 Q2
7 quarters
|
|
Similar funds
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.